Clinical Trials Sponsored by Alpha Tau Medical LTD.

Total 60 results

Alpha Tau Medical LTD.

Not yet recruiting

A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Breast Cancer | Breast Carcinoma | Recurrent Breast Cancer

Israel
Alpha Tau Medical LTD.

Recruiting

A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC

Skin Cancer | Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma

Israel
Alpha Tau Medical LTD.

Recruiting

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Israel
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer

Canada
Alpha Tau Medical LTD.

Recruiting

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer

Israel
Alpha Tau Medical LTD.

Recruiting

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Recurrent Squamous Cell Carcinoma

United States, Israel
Alpha Tau Medical LTD.

Recruiting

Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer

Prostate Adenocarcinoma

Israel
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

Skin Cancer | Cutaneous Tumor | Cutaneous Metastasis

France
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Italy
Alpha Tau Medical LTD.

Active, not recruiting

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Israel
Alpha Tau Medical LTD.

Not yet recruiting

A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer

Non-metastatic Prostate Cancer | Locally Recurrent Prostate Cancer

Israel
Alpha Tau Medical LTD.

Not yet recruiting

Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).

Carcinoma of the Vulva | Recurrent Carcinoma of the Vulva
Alpha Tau Medical LTD.

Not yet recruiting

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer

Pancreatic Cancer | Pancreatic Adenocarcinoma | Unresectable Pancreatic Cancer
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT)

Liver Metastases

Canada
Alpha Tau Medical LTD.

Recruiting

A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors

Malignant Tumor

Israel
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer

Lung Cancer | Recurrent Lung Cancer

Israel
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Israel
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Skin Cancer | Mucosal Neoplasm of Oral Cavity | Soft Tissue Neoplasm

Israel
Alpha Tau Medical LTD.

Terminated

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.Pathology

Russian Federation
Alpha Tau Medical LTD.

Completed

Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors

Malignant Skin Tumor | Soft Tissue Tumor, Malignant

United States
Alpha Tau Medical LTD.

Completed

A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT

Squamous Cell Carcinoma | DaRT Treated Patients

Italy, Israel
Alpha Tau Medical LTD.

Completed

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)

Skin Squamous Cell Carcinoma

Italy
Alpha Tau Medical LTD.

Completed

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)

Squamous Cell Carcinoma

Israel
Alpha Tau Medical LTD.
European Organisation for Research and Treatment of Cancer - EORTC

Not yet recruiting

Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC

Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma

Israel
CCTU- Cancer Theme
Alpha Tau Medical LTD.

Recruiting

A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer (DaRT-V)

Vulvar Squamous Cell Carcinoma | Vulva Cancer, Recurrent | Vulva Cancer

United Kingdom
Tau Pnu Medical Co., Ltd.

Completed

Evaluation of Safety and Efficacy of Pivot Balloon to Monitoring Acute RV Failure and Reduction of FTR

Functional Tricuspid Regurgitation

Korea, Republic of
Tau Pnu Medical Co., Ltd.

Completed

The Effect of "Cerclage Pacing" for the Heart Failure Patients Who Need Cardiac Resynchronization Therapy (CRT) (Cerclage-CRT)

Heart Failure | LBBB Complete

Korea, Republic of
Tau Pnu Medical Co., Ltd.

Completed

Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation

Heart Failure | Functional Mitral Regurgitation

United States, Korea, Republic of
Tau Pnu Medical Co., Ltd.

Recruiting

The Study for Evaluate of Safety and Efficacy of Vein of Marshall RF Ablation

Persistent Atrial Fibrillation

Korea, Republic of
Tau Pnu Medical Co., Ltd.

Recruiting

First-in-Man Early Feasibility Study for Transcatheter HOCM Septal Ablation

Hypertrophic Obstructive Cardiomyopathy

Korea, Republic of
Tau Pnu Medical Co., Ltd.

Completed

The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat FTR

Functional Tricuspid Regurgitation

Korea, Republic of
Tau Pnu Medical Co., Ltd.

Completed

Atrial Functional Mitral Regurgitation Response In Mitral Loop Cerclage Annuloplasty (AFRICA Study) (AFRICA)

Heart Failure | Atrial Functional Mitral Regurgitation

Korea, Republic of
Rabin Medical Center
Alpha Net Co. Ltd.

Completed

Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients

Conjunctivitis | Epiphora

Israel
Alpha Omega Engineering Ltd.
University of Colorado, Denver; Hadassah Medical Organization; Swedish Medical...

Completed

Validation of HaGuide Software Module Accuracy in Mapping STN Boundaries in Parkinson's Disease Patients Who Underwent DBS Procedure

Parkinson Disease | Deep Brain Stimulation
Tayu Huaxia Biotech Medical Group Co., Ltd.

Recruiting

A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas

Locally Advanced /Metastatic Solid Tumors | Relapsed or Refractory Lymphomas

China
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...
Morris Enterprise Co.,Ltd.

Enrolling by invitation

Double-Blind, Placebo-Controlled Trial of Eefooton in Patients With Chronic Kidney Disease

Urologic Diseases | Chronic Kidney Diseases | Renal Insufficiency, Chronic

Taiwan
Neurobit Technologies Co., Ltd.
Taipei Medical University; Buddhist Tzu Chi Medical Foundation

Completed

AIVertigo: AIVertigo: Automated Differential Diagnosis of Vertigo Using Video-oculography and Advanced Artificial Intelligence-based Triage

Vertigo

Taiwan
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Nanjing Medical University

Completed

A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics (ALTN)

Advanced Cancer

China
Peking Union Medical College Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib or Penpulimab in Combination With RAI for DTC

Thyroid Cancer

China
Nanfang Hospital of Southern Medical University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Unresectable Stage III Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043) (ALTER-L043)

Resectable Locally Advanced Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study

Refractory or Recurrent Neuroblastoma in Children
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC (ALTER-L004)

Non Small Cell Lung Cancer

China
First Affiliated Hospital of Wenzhou Medical University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Interstitial Lung Diseases

China
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790M (ALTN-03)

Non Small Cell Lung Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital

Unknown

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors

Non Small Cell Lung Cancer

China
The First Affiliated Hospital with Nanjing Medical...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma (EXPLORING)

Digestive System Diseases | Gastrointestinal Diseases | Carcinoma | Gastrointestinal Neoplasms | Stomach Cancer | Gastric Cancer | Gastroesophageal-junction Cancer

China
Peking Union Medical College Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Xinda Biopharmaceutical Group

Not yet recruiting

Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
The First Affiliated Hospital with Nanjing Medical...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

the Accuracy and Safety of Coronary Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle

Coronary Heart Disease

China

Clinical Trials Sponsored by Alpha Tau Medical LTD.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations